Glen Harbor Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Glen Harbor Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$264K	Buy	6,468 +196	+3%	+$8.46K	0.01%	927
2019 Q2	$302K	Buy	6,272 +728	+13%	+$38.3K	0.01%	887
2019 Q1	$347K	Buy	5,544 +112	+2%	+$7.69K	0.01%	816
2018 Q4	$324K	Buy	5,432 +224	+4%	+$13.4K	0.01%	774
2018 Q3	$336K	Buy	5,208 +1,148	+28%	+$64.1K	0.01%	872
2018 Q2	$183K	Hold	4,060	–	–	﹤0.01%	1000
2018 Q1	$126K	Hold	4,060	–	–	﹤0.01%	1104
2017 Q4	$121K	Buy	4,060 +980	+32%	+$28.4K	﹤0.01%	1119
2017 Q3	$102K	Buy	3,080 +448	+17%	+$15.5K	﹤0.01%	1118
2017 Q2	$88K	Buy	2,632 +1,092	+71%	+$32.6K	﹤0.01%	1116
2017 Q1	$45K	Buy	+1,540	New	+$38.1K	﹤0.01%	1142

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Glen Harbor Capital Management's BEAT Position: Q3 2019 in Review

Glen Harbor Capital Management increased its BioTelemetry, Inc. (BEAT) stake by 3.1% in Q3 2019, buying an estimated $8.46K and bringing the position to 6,468 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #927.

Glen Harbor Capital Management first reported a position in BEAT in Q1 2017 and has held it in 11 quarters since. The position peaked at $347K in Q1 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

Glen Harbor Capital Management held 6,468 shares of BioTelemetry, Inc. worth $264K as of Q3 2019.
Glen Harbor Capital Management bought 196 BioTelemetry, Inc. shares in Q3 2019, an estimated $8.46K.
BioTelemetry, Inc. made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #927 holding.
Glen Harbor Capital Management first reported a position in BioTelemetry, Inc. in Q1 2017 and has held it in 11 quarters since.
Glen Harbor Capital Management's BioTelemetry, Inc. position peaked at $347K in Q1 2019.
219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.